Email address
[email protected]Contact number
0161 672 1528Share profile
Band 1
Provided by Simon Wallwork
Simon Wallwork is a Director of and Corporate Lawyer at Slater Heelis Solicitors, based in Manchester.
With over 35 years of experience advising on acquisitions, disposals, fundraising, private equity and public market transactions, for a wide variety of clients including public and private companies, banks, venture capital funds and partnerships. He also advises on Corporate Governance issues.
Simon also has considerable client-side experience spending a number of years working in-house with Pilkington plc.
In addition to general corporate work, Simon specialises in the Technology and Life Sciences sectors. He has built up expertise in these sectors developing a deep understanding of their drivers.
He has been consistently ranked as one of the top corporate transactional lawyers in the North West according to Experian and held top positions for Most Active Legal Adviser in Manchester.
Trainee Solicitor - Elliot & Company 1986 to 1988
In-house Counsel - Pilkington Plc 1988 to 1990
Assistant Solicitor - Fox Brooks Marshall 1990 to 1994
Partner - Wacks Caller Solicitors 1994 to 2002
Partner - Pannone LLP 2002 to 2011
Partner - Semple Fraser 2011 to 2013
Partner - Weightmans 2013 to 2014
Partner/Director - Slater Heelis 2014 to present
Hasgrove Limited
Gen2 Limited
Talisman Therapeutics
Quantum Science Limited
Ubiquigent Limited
Mottram Interiors Group Limited
Monument Thrapeutics
DBD
Phoenix Optical Glass
Technology, Life Sciences
England and Wales
English
Provided by Chambers
Simon Wallwork heads the firm's corporate team. He handles a wide range of transactions relating to M&A, private equity and fundraising, with particular expertise in the life sciences sector.
Provided by Chambers
Simon Wallwork provides unwavering support under high-pressure situations.
Simon is an outstanding person and lawyer. I couldn't recommend him enough.
Simon Wallwork is a go-to person for sizeable transactions. He takes responsibility and takes charge of deals. He's a leader in transactional work.
Simon is very approachable and has outstanding commercial awareness. His attention to detail and support in some challenging situations is consistently second to none. He is very client-focused.
Simon Wallwork provides unwavering support under high-pressure situations.
Simon is an outstanding person and lawyer. I couldn't recommend him enough.
Simon Wallwork is a go-to person for sizeable transactions. He takes responsibility and takes charge of deals. He's a leader in transactional work.
Simon is very approachable and has outstanding commercial awareness. His attention to detail and support in some challenging situations is consistently second to none. He is very client-focused.
4 items provided by Slater Heelis
SOFTWARE INNOVATOR SOLD TO LISTED US GROUP
A Greater Manchester software and technology provider has been acquired by a NASDAQ-listed firm. Grant Thornton UK LLP's corporate finance team has advised on the international sale of KMP Associates.
Navigating the medtech funding landscape
Simon Wallwork, partner and head of the corporate and commercial team at Slater Heelis, shares his advice for medtech companies at all stages of their development - from attracting investment and funding to taking the steps from start-up to scaleup to ultimately, a listed company.
SLATER HEELIS ADVISES ON AIM ENTRY FOR BIOTECH DEVELOPING NEXT-GENERATION CANCER THERAPIES
BiVictriX floats on AIM with gross proceeds of £7.5m and market capitalisation at £13.2m
KATHARINE MELLOR WINS LIFETIME ACHIEVEMENT AWARD
Manchester Law Society’s first female President takes home Manchester Legal Awards’ prestigious award.
SOFTWARE INNOVATOR SOLD TO LISTED US GROUP
A Greater Manchester software and technology provider has been acquired by a NASDAQ-listed firm. Grant Thornton UK LLP's corporate finance team has advised on the international sale of KMP Associates.
Navigating the medtech funding landscape
Simon Wallwork, partner and head of the corporate and commercial team at Slater Heelis, shares his advice for medtech companies at all stages of their development - from attracting investment and funding to taking the steps from start-up to scaleup to ultimately, a listed company.
SLATER HEELIS ADVISES ON AIM ENTRY FOR BIOTECH DEVELOPING NEXT-GENERATION CANCER THERAPIES
BiVictriX floats on AIM with gross proceeds of £7.5m and market capitalisation at £13.2m
KATHARINE MELLOR WINS LIFETIME ACHIEVEMENT AWARD
Manchester Law Society’s first female President takes home Manchester Legal Awards’ prestigious award.
Provided by Slater Heelis
Health and Life Sciences
Technology, Media and Telecoms (TMT)
